These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7355762)

  • 1. Dose requirements of hydralazine in patients with severe chronic congestive heart failure.
    Packer M; Meller J; Medina N; Gorlin R; Herman MV
    Am J Cardiol; 1980 Mar; 45(3):655-60. PubMed ID: 7355762
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of hydralazine therapy in patients with chronic congestive heart failure].
    Ke YN
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):149-51, 190. PubMed ID: 3622085
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
    Elkayam U; Weber L; McKay CR; Rahimtoola SH
    Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine in the management of left ventricular failure.
    Fitchett DH; Neto JA; Oakley CM; Goodwin JF
    Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
    [No Abstract]   [Full Text] [Related]  

  • 7. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    Haitas B; Meyer TE; Angel ME; Reef E
    Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].
    Dumitriu M; Costică II; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):349-63. PubMed ID: 6150539
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M; Gorlin R
    N Engl J Med; 1982 Jan; 306(2):57-62. PubMed ID: 7053487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine in the management of chronic congestive heart failure.
    Rosenblum R
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1664. PubMed ID: 4003322
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of hydralazine on arrhythmias in congestive cardiomyopathy.
    Heer KR; Davies J; MacArthur CG
    Int J Cardiol; 1981; 1(2):117-21. PubMed ID: 7338416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The changes in plasma catecholamine and hemodynamics in the treatment of chronic congestive heart failure with hydralazine].
    Ke YN
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):9-12. PubMed ID: 6745077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hydralazine in chronic heart failure].
    Conradson TB; Rydén L
    Lakartidningen; 1984 Sep; 81(38):3354-5. PubMed ID: 6482605
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure.
    Binkley PF; Starling RC; Hammer DF; Leier CV
    Am J Cardiol; 1991 Oct; 68(10):1103-6. PubMed ID: 1927930
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of hydralazine on systemic hemodynamics in patients with cardiac insufficiency].
    Koshlia VI
    Klin Med (Mosk); 1985 Oct; 63(10):100-2. PubMed ID: 4079283
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.